Literature DB >> 11554903

Effects of hyperventilation on fast goal-directed limb movements in spinocerebellar ataxia type 6.

M U Manto1.   

Abstract

It has been shown previously that hyperventilation modifies the features of the nystagmus in cerebellar patients (Walker and Zee, 1999). It has been hypothesized that hyperventilation influences the oculomotor control through a metabolic effect on cerebellar calcium channels, which play a critical role in the firing behaviour of neuronal populations in the cerebellum. This hypothesis has been tested here by analysing fast goal-directed limb movements before and after hyperventilation in spinocerebellar ataxia type 6 (SCA-6), a disease associated with a polyglutamine expansion in the alpha 1-A voltage-dependent calcium channel. Cerebellar hypermetria associated with fast distal single-joint movements was found to be increased following hyperventilation in patients presenting SCA-6 but remained unchanged in patients with idiopathic late-onset cerebellar degeneration (ILOCA). This is a new provocative test to enhance distal dysmetria in SCA-6. The present results strengthen the hypothesis of Walker and Zee. It is suggested that hyperventilation enhances the defective calcium transfers in SCA-6, resulting in an impairment of the calcium influx in particular into Purkinje cells involved in the control of fast goal-directed voluntary movements.

Entities:  

Mesh:

Year:  2001        PMID: 11554903     DOI: 10.1046/j.1468-1331.2001.00252.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  2 in total

1.  Exercise-induced downbeat nystagmus in a Korean family with a nonsense mutation in CACNA1A.

Authors:  Jae-Hwan Choi; Jae-Deuk Seo; Yu Ri Choi; Min-Ji Kim; Jin-Hong Shin; Ji Soo Kim; Kwang-Dong Choi
Journal:  Neurol Sci       Date:  2015-03-18       Impact factor: 3.307

2.  A second mechanism of increase of cerebellar hypermetria in humans.

Authors:  Mario-Ubaldo Manto; Pierre Bosse
Journal:  J Physiol       Date:  2003-02-14       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.